Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.

× No keyword cloud information.

11 in total

1. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.

Authors: P A Phillips-Howard; L J West
Journal: J R Soc Med Date: 1990-02 Impact factor: 5.344

Review 2. Toxicity of antimalarial drugs.

Authors: T E Peto
Journal: J R Soc Med Date: 1989 Impact factor: 5.344

3. Development of recommendations for the protection of short-stay travellers to malaria endemic areas: Memorandum from two WHO Meetings.

Authors:
Journal: Bull World Health Organ Date: 1988 Impact factor: 9.408

4. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.

Authors: U Hellgren; L Rombo; B Berg; J Carlson; B E Wiholm
Journal: Br Med J (Clin Res Ed) Date: 1987-08-08

5. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy.

Authors: R Steffen; R Heusser; R Mächler; R Bruppacher; U Naef; D Chen; A M Hofmann; B Somaini
Journal: Bull World Health Organ Date: 1990 Impact factor: 9.408

Review 6. Prevention of malaria.

Authors: J S Keystone
Journal: Drugs Date: 1990-03 Impact factor: 9.546

Review 7. Adverse effects of antimalarials. An update.

Authors: G A Luzzi; T E Peto
Journal: Drug Saf Date: 1993-04 Impact factor: 5.606

Review 8. Antimalarial drug toxicity: a review.

Authors: W Robert J Taylor; Nicholas J White
Journal: Drug Saf Date: 2004 Impact factor: 5.606

9. How frequent are notified severe cutaneous adverse reactions to Fansidar?

Authors: D Stürchler; M L Mittelholzer; L Kerr
Journal: Drug Saf Date: 1993-02 Impact factor: 5.606

Review 10. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.

Authors: Philip J Peters; Michael C Thigpen; Monica E Parise; Robert D Newman
Journal: Drug Saf Date: 2007 Impact factor: 5.606